Scientists from Paul Scherrer Institute and University College London developed bioactive nanoparticles that cleared toxic proteins in mice, reversing Alzheimer’s symptoms and restoring cognition, offering a potential shift toward vascular repair-based therapies for neurodegenerative diseases
Researchers have reversed Alzheimer’s symptoms in mice using bioactive nanoparticles that restore blood-brain barrier function. The therapy rapidly cleared toxic amyloid-beta and improved behavior, highlighting vascular health as a promising new target for human Alzheimer’s treatments.
New Delhi: Efforts to unravel the mystery around the highly debilitating disease of Alzheimer’s have got a shot in the arm with a recent study getting newer insight into the biomolecular mechanism for the formation of protein clusters/aggregates that are often seen in the disease. Proteins are essential for virtually every process within the cell. […]
